<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Underwriting, Not Promoting</title>
    <meta content="LTR045946" name="slug"/>
    <meta content="3" name="publication_day_of_month"/>
    <meta content="9" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Sunday" name="publication_day_of_week"/>
    <meta content="Money and Business/Financial Desk" name="dsk"/>
    <meta content="16" name="print_page_number"/>
    <meta content="3" name="print_section"/>
    <meta content="3" name="print_column"/>
    <meta content="Business; Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1227761"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Marketing and Merchandising</classifier>
        <classifier class="indexing_service" type="descriptor">Antibiotics</classifier>
        <classifier class="indexing_service" type="descriptor">Zithromax (Drug)</classifier>
        <org class="indexing_service">Pfizer Inc</org>
        <person class="indexing_service">Bloom, Linda</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Antibiotics</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Advertising and Marketing</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000903T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9A00E3DA1030F930A3575AC0A9669C8B63" item-length="123" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Underwriting, Not Promoting</hl1>
      </hedline>
      <abstract>
        <p>Linda Bloom letter on August 27 article o Pfizer Inc's marketing of new drugs lauds effectiveness of antibiotic Zithromax (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>While Pfizer may be working overtime in its marketing of Zithromax to doctors, the word-of-mouth factor has also been effective.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>While Pfizer may be working overtime in its marketing of Zithromax to doctors, the word-of-mouth factor has also been effective.</p>
        <p>When my 7-year-old son got an ear infection recently, two different parents told me I should ask for Zithromax. Since he still had a week of day camp ahead of him, to be followed by our family vacation, the idea of one daily dose for only five days was appealing.</p>
        <p>If I had not requested Zithromax, the doctor would have prescribed a 10-day antibiotic. My son recovered nicely, by the way.</p>
        <p>LINDA BLOOM  New York City, Aug. 28</p>
      </block>
    </body.content>
  </body>
</nitf>
